The typographical corrections below were made to the article on the date noted. These changes have been incorporated in the article and the details are documented here.

24 March 2005:

In the "Intravitreal injections" section of Methods, the concentration of α2-antiplasmin injected into treated eyes was corrected to 4 μg/2 μl; it was originally listed as 4 ng/2 μl.